COMPANY
FRESENIUS KABI CANADA LTD
FRESENIUS KABI CANADA LTD: marketing authorisation holder for Bacitracin, Colistin, Oxytocin, Vancomycin, Vasopressin, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Bacitracin | BACITRACIN FOR INJECTION (DIN 02255820), Cancelled Pre Market Regulator Health Canada |
|---|---|
| Colistin | COLISTIMETHATE FOR INJECTION, USP (DIN 02403544), Marketed Regulator Health Canada |
| Oxytocin | OXYTOCIN INJECTION, USP (DIN 02139561), Marketed Regulator Health Canada |
| Vancomycin | VANCOMYCIN HYDROCHLORIDE CAPSULES, USP (DIN 02377470), Cancelled Post Market Regulator Health Canada |
| Vancomycin | VANCOMYCIN HYDROCHLORIDE CAPSULES, USP (DIN 02377489), Cancelled Post Market Regulator Health Canada |
| Vancomycin | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02139243), Marketed Regulator Health Canada |
| Vancomycin | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02139375), Marketed Regulator Health Canada |
| Vancomycin | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02139383), Marketed Regulator Health Canada |
| Vancomycin | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (DIN 02241807), Marketed Regulator Health Canada |
| Vasopressin | VASOPRESSIN INJECTION, USP (DIN 02139502), Marketed Regulator Health Canada |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.